title: Immunohistochemical localization of oxytocin receptors in human brain.
abstract: The neuropeptide oxytocin (OT) regulates rodent, primate and human social behaviors and stress responses. OT binding studies employing (125)I-d(CH2)5-[Tyr(Me)2,Thr4,Tyr-NH2(9)] ornithine vasotocin ((125)I-OTA), has been used to locate and quantify OT receptors (OTRs) in numerous areas of the rat brain. This ligand has also been applied to locating OTRs in the human brain. The results of the latter studies, however, have been brought into question because of subsequent evidence that (125)I-OTA is much less selective for OTR vs. vasopressin receptors in the primate brain. Previously we used a monoclonal antibody directed toward a region of the human OTR to demonstrate selective immunostaining of cell bodies and fibers in the preoptic-anterior hypothalamic area and ventral septum of a cynomolgus monkey (Boccia et al., 2001). The present study employed the same monoclonal antibody to study the location of OTRs in tissue blocks containing cortical, limbic and brainstem areas dissected from fixed adult, human female brains. OTRs were visualized in discrete cell bodies and/or fibers in the central and basolateral regions of the amygdala, medial preoptic area (MPOA), anterior and ventromedial hypothalamus, olfactory nucleus, vertical limb of the diagonal band, ventrolateral septum, anterior cingulate and hypoglossal and solitary nuclei. OTR staining was not observed in the hippocampus (including CA2 and CA3), parietal cortex, raphe nucleus, nucleus ambiguus or pons. These results suggest that there are some similarities, but also important differences, in the locations of OTRs in human and rodent brains. Immunohistochemistry (IHC) utilizing a monoclonal antibody provides specific localization of OTRs in the human brain and thereby provides opportunity to further study OTR in human development and psychiatric conditions.
authors.affiliation: FPG Child Development Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-8185, United States. Electronic address: Dr.boccia@gmail.com.
authors.forename: M L
authors.initials: ML
authors.lastname: Boccia
authors.forename: P
authors.initials: P
authors.lastname: Petrusz
authors.forename: K
authors.initials: K
authors.lastname: Suzuki
authors.forename: L
authors.initials: L
authors.lastname: Marson
authors.forename: C A
authors.initials: CA
authors.lastname: Pedersen
mesh_terms: D000328:Adult; D001345:Autoradiography; D001706:Biopsy; D001921:Brain / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D006727:Hormone Antagonists / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D010121:Oxytocin / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D018045:Receptors, Oxytocin / Q000378:metabolism*; D014599:Uterus / Q000378:metabolism
chemical_list: D006727:Hormone Antagonists; C055830:KB 5-21; D018045:Receptors, Oxytocin; D010121:Oxytocin
keywords: IHC; MPOA; OT; OT receptors; OTRs; VMN; human brain; hypothalamus; immunohistochemistry; limbic system; medial preoptic area; oxytocin; oxytocin receptor; ventromedial nucleus of the hypothalamus